Need any help? Call us on

+44 (0) 1270 258200

Controlled Drugs Regulatory Update –…

Controlled Drugs Regulatory Update – Online Clinic

9 May 2022


Following discussions with Industry bodies, the Home Office has announced that the proposed amendment to the Misuse of Drugs Regulations 2001 to include gamma Butyrolactone (GBL) and 1,4-Butanediol (1,4 BD / BDO) into schedule 1, which was laid before Parliament on the 15 December 2015, will be revoked. Therefore, the requirement to obtain a licence for the import, export, production, supply, or possession will not enter into force on June 15th, 2022.

However, the substances are still controlled drugs and have been subsequently reclassified within the ‘Misuse of Drugs Act’ from class ‘C’ to class ‘B’ drugs. It is therefore still important to handle these substances carefully and considerately, to understand your supply chain and know your customers accordingly.

This short clinic is designed to:
•Recap the journey so far
•Clarify the current position
•Explain ‘Know Your Customer’ principle
•The relevance to ‘Responsible Distribution’

This is the latest in our ongoing series of “Online Clinics” and “Best Practice Workshops,” part of our new initiative to increase the value of membership. Watch out for other such events going forward.

Add to Outlook Calendar Calendar icon31 Tweet Event


Back to Events